Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Almirall, S.A. (E2Z.F) Follow Add holdings 9.71 +0.05 +(0.52%) As of 8:02:53 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for E2Z.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: E2Z.F View More All News Press Releases SEC Filings 3 European Stocks Estimated To Be Undervalued By Up To 44.8% Almirall's 16th Skin Academy Brings Together Leading Experts to Advance Skin Science and Treatment Options in Medical Dermatology AAD 2025: Almirall presents early-stage pipeline progress and real-world evidence on demonstrating AK treatment success and patient satisfaction with Tirbanibulin Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025 Three Stocks With Estimated Undervaluation Worth Considering In February 2025 Almirall SA (LBTSF) Q4 2024 Earnings Call Highlights: Surpassing Expectations with Strong ... Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline JP Morgan 2025: Almirall updates strategy with focus on medical dermatology Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth Almirall Launches The Hive, Creating a Novel Collaborative Innovation Hub to Advance Life Sciences and Healthcare Eloxx Pharmaceuticals Announces Key Corporate Accomplishments